Agilent Technologies, Inc.

Equities

A

US00846U1016

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
130.4 ^USD	-0.77%		-13.44%	-6.20%

May. 30	A new phase for the market
May. 30	UBS Cuts Price Target on Agilent Technologies to $141 From $155, Keeps Neutral Rating	MT

Agilent to Participate in Jefferies Global Healthcare Conference

May 17, 2024 at 02:31 pm EDT

Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City on Wednesday, June 5, at 8:30 a.m. EDT.

Those interested in listening to the live or recorded session can access it from the Agilent Investor Relations website. The recording will be available for 90 days.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240517008367/en/

Latest news about Agilent Technologies, Inc.

A new phase for the market	May. 30
UBS Cuts Price Target on Agilent Technologies to $141 From $155, Keeps Neutral Rating	May. 30	MT
Wolfe Research Adjusts Agilent Technologies' PT to $135 From $155	May. 30	MT
Leerink Adjusts Price Target on Agilent Technologies to $135 From $150	May. 30	MT
Stifel Adjusts Price Target on Agilent Technologies to $151 From $163	May. 30	MT
JPMorgan Adjusts Price Target on Agilent Technologies to $155 From $165	May. 30	MT
Bernstein Adjusts Price Target on Agilent Technologies to $125 From $130	May. 30	MT
TD Cowen Adjusts Price Target on Agilent Technologies to $153 From $163	May. 30	MT
Citigroup Adjusts Price Target on Agilent Technologies to $135 From $145	May. 30	MT
Baird Adjusts Price Target on Agilent Technologies to $136 From $147	May. 30	MT
Goldman Sachs Adjusts Price Target on Agilent Technologies to $145 From $165	May. 30	MT
Evercore ISI Adjusts Price Target on Agilent Technologies to $126 From $145	May. 30	MT
North American Morning Briefing : Equity Futures Struggle as Bond Yields Hold Highs	May. 30	DJ
Agilent lowers full-year revenue forecast on slowing demand from its biotech clients	May. 29	RE
Agilent Technologies Fiscal Q2 Non-GAAP Earnings, Revenue Fall; Full Year Guidance Cut -- Shares Down After Hours	May. 29	MT
Transcript : Agilent Technologies, Inc., Q2 2024 Earnings Call, May 29, 2024	May. 29
Agilent Technologies Guides For Full Year 2024 EPS of $5.15-$5.25 on Revenue of $6.42-$6.5 Billion, vs CIQ Analyst Consensus of $5.65/Share on Revenue of $6.9 Billion	May. 29	MT
Agilent Technologies Guides For Q3 EPS of $1.25-$1.28 on Revenue of $1.535-$1.575 Billion, vs CIQ Analyst Consensus of $1.45/Share on Revenue of $1.72 Billion	May. 29	MT
Earnings Flash (A) AGILENT TECHNOLOGIES Reports Q2 Revenue $1.57B, vs. Street Est of $1.58B	May. 29	MT
Earnings Flash (A) AGILENT TECHNOLOGIES Reports Q2 EPS $1.22, vs. Street Est of $1.19	May. 29	MT
Agilent Technologies, Inc. (NYSE:A) announces an Equity Buyback for $2,000 million worth of its shares.	May. 29	CI
Agilent Technologies, Inc. Provides Financial Guidance for the Third Quarter of Fiscal 2024 and Revises Financial Guidance for the Full Year of Fiscal 2024	May. 29	CI
Agilent Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	May. 29	CI
Equities Lower as Markets Await Thursday's GDP Report	May. 29	MT
Global markets live: BHP, Anglo American, Lenovo, Nvidia, Apple...	May. 29

Chart Agilent Technologies, Inc.

Duration

Period

More charts

Company Profile

Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (73.9%) and services (26.1%). Net sales are distributed geographically as follows: the United States (40%), China (34.3%) and other (25.7%).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-05 - Jefferies Global Healthcare Conference - Fireside Chat

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Agilent Technologies, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

130.4 USD

Average target price

141.1 USD

Spread / Average Target

+8.21%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.48%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.61B
RESMED, INC.	+19.95%	30.31B

Other Advanced Medical Equipment & Technology